Simplify Logo

Full-Time

Director – Regulatory CMC

Posted on 2/7/2024

Cerevel Therapeutics

Cerevel Therapeutics

201-500 employees

Develops neuroscience therapies for CNS disorders

Hardware
Biotechnology

Senior, Expert

Remote in USA

Category
Legal
Risk & Compliance
Legal & Compliance
Required Skills
Communications
Marketing
Requirements
  • Minimum of 10 years of experience working in the pharmaceutical/biotechnology industry with direct experience in CMC Regulatory Affairs
  • Regulatory Affairs Certification (RAC) a plus
  • Demonstrated experience in the preparation and submission of INDs, CTAs, and NDAs/Marketing Applications
  • Experience with Health Authority reviews, queries and responses
  • Expert knowledge with GMP/ICH requirements and guidance in major markets, especially US and EU
  • Excellent written and verbal communication skills
  • Strategic thinker, planner with excellent organizational skills
  • Proven ability to effectively work collaboratively in cross functional teams
Responsibilities
  • Create and deliver effective CMC strategies with appropriate risk assessment for projects across the development spectrum
  • Partner with Global Regulatory Lead and Technical Operations Team lead to ensure CMC risks are appropriately communicated to Product Teams and senior management
  • Serve as primary author of Module 3 documentation for regulatory submissions while partnering with cross functional SMEs
  • Provide strategic input to technical teams to ensure product development meets global regulatory requirements
  • Review and provide assessments for change controls partnering with Quality colleagues to ensure investigational and commercial products maintain regulatory compliance
  • Provide and communicate CMC regulatory/GMP guidance documents and regulations regarding applicability and impact to internal programs
  • Assist in the development, writing and implementation of internal guidance documentation for CMC regulatory and technical operations colleagues
  • Engage in appropriate activities in order to influence the regulatory environment through Health Authorities contacts and Trade Associations (eg, BIO) as appropriate

Cerevel Therapeutics is dedicated to developing experimental neuroscience therapies for central nervous system disorders, focusing on understanding neurocircuitry deficits to unlock new treatment opportunities.

Company Stage

IPO

Total Funding

$1.8B

Headquarters

Cambridge, Massachusetts

Founded

2018

Growth & Insights
Headcount

6 month growth

9%

1 year growth

11%

2 year growth

32%
INACTIVE